Shanghai Rendu Ownership

688193 Stock   37.18  0.45  1.20%   
Shanghai Rendu Biote shows a total of 40 Million outstanding shares. Shanghai Rendu Biote has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 60.11 % of Shanghai Rendu outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Shanghai Rendu in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Shanghai Rendu, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shanghai Rendu Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Shanghai Stock Ownership Analysis

About 60.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.62. In the past many companies with similar price-to-book ratios have beat the market. Shanghai Rendu Biote last dividend was issued on the 30th of October 2024. For more info on Shanghai Rendu Biotechnology please contact the company at 86 21 5072 0200 or go to https://www.rdbio.com.

Shanghai Rendu Outstanding Bonds

Shanghai Rendu issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Shanghai Rendu Biote uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Shanghai bonds can be classified according to their maturity, which is the date when Shanghai Rendu Biotechnology has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

Shanghai Rendu financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Rendu security.